| Children's Hospital Corporation |
Level II |
10 | 10 |
$75,971 |
| Children's Hospital Corporation |
Level III |
4 | 4 |
$100,000 |
| Eli Lilly and Company |
Level III |
4 | 4 |
$123,495 |
| Lonza Biologics Inc. |
Level IV |
4 | 4 |
$155,700 |
| ModernaTX, Inc. |
Level IV |
4 | 4 |
$142,900 |
| Alten Technology USA, Inc. |
Level I |
3 | 3 |
$87,000 |
| Eli Lilly and Company |
Level II |
3 | 3 |
$112,189 |
| General Hospital Corporation |
Level III |
3 | 3 |
$86,382 |
| Sanofi US Services Inc. |
Level IV |
3 | 3 |
$136,552 |
| Beaver-Visitec International, Inc. |
Level I |
2 | 2 |
$88,046 |
| Boston Scientific Corporation |
Level III |
2 | 2 |
$130,000 |
| Eli Lilly and Company |
Level IV |
2 | 2 |
$148,000 |
| GC Therapeutics, Inc. |
Level IV |
2 | 2 |
$248,689 |
| Insulet Corporation |
Level IV |
2 | 2 |
$150,000 |
| Massachusetts Institute of Technology |
Level I |
2 | 2 |
$72,154 |
| Moderna Services, Inc. |
Level III |
2 | 2 |
$124,363 |
| NxStage Medical, Inc., a Fresenius Medical Care N.A. Company |
Level I |
2 | 2 |
$95,813 |
| NxStage Medical, Inc., a Fresenius Medical Care N.A. Company |
Level II |
2 | 2 |
$108,250 |
| Spaulding Rehabilitation Hospital |
Level I |
2 | 2 |
$54,600 |
| Tufts University |
Level I |
2 | 2 |
$69,000 |
| 3Key Consulting, Inc. |
Level I |
1 | 1 |
$86,299 |
| Aldevron, LLC |
Level IV |
1 | 1 |
$142,000 |
| Amgen Inc. |
Level IV |
1 | 1 |
$161,000 |
| Analog Devices, Inc. |
Level III |
1 | 1 |
$173,250 |
| Arranta Bio MA LLC |
Level IV |
1 | 1 |
$148,271 |
| B.A.I. Technologies, Inc. |
Level III |
1 | 1 |
$120,000 |
| Biogen, Inc. |
Level I |
1 | 1 |
$86,299 |
| Biogen, Inc. |
Level III |
1 | 1 |
$119,808 |
| Boston Scientific Corporation |
Level II |
1 | 1 |
$103,043 |
| Boston Scientific Corporation |
Level IV |
1 | 1 |
$136,552 |
| Brigham and Women's Hospital |
Level II |
1 | 1 |
$75,000 |
| The Broad Institute, Inc. |
Level I |
1 | 1 |
$70,000 |
| The Broad Institute, Inc. |
Level II |
1 | 1 |
$72,100 |
| CALDWELL INTELLECTUAL PROPERTY LAW LLC |
Level III |
1 | 1 |
$130,000 |
| Candela Corporation |
Level III |
1 | 1 |
$125,000 |
| CELLVIRA LLC |
Level II |
1 | 1 |
$110,000 |
| CHMC Anesthesia Foundation, Inc. |
Level II |
1 | 1 |
$88,695 |
| Corixa Corporation |
Level II |
1 | 1 |
$103,043 |
| Covidien LP |
Level III |
1 | 1 |
$119,808 |
| Cyberbahn Federal Solutions, LLC |
Level II |
1 | 1 |
$111,000 |
| DPS Group, Inc. |
Level IV |
1 | 1 |
$152,000 |
| ElevateBio Technologies, Inc. |
Level I |
1 | 1 |
$86,299 |
| EMD Serono Research and Development Institute, Inc. |
Level IV |
1 | 1 |
$225,000 |
| Fresenius USA Marketing, Inc., a Fresenius Medical Care N.A. company |
Level IV |
1 | 1 |
$164,943 |
| General Hospital Corporation |
Level I |
1 | 1 |
$62,004 |
| General Hospital Corporation |
Level II |
1 | 1 |
$70,450 |
| General Hospital Corporation |
Level IV |
1 | 1 |
$102,315 |
| Ginkgo Bioworks, Inc. |
Level I |
1 | 1 |
$86,299 |
| Ginkgo Bioworks, Inc. |
Level III |
1 | 1 |
$119,808 |
| Ginkgo Bioworks, Inc. |
Level IV |
1 | 1 |
$163,800 |
| Global Life Sciences Solutions USA LLC |
Level IV |
1 | 1 |
$168,585 |
| Hologic, Inc. |
Level III |
1 | 1 |
$126,198 |
| Instrumentation Laboratory Company |
Level II |
1 | 1 |
$103,043 |
| Instrumentation Laboratory Company |
Level III |
1 | 1 |
$165,000 |
| IPG Medical Corporation |
Level IV |
1 | 1 |
$145,000 |
| Kernal Biologics, Inc. |
Level II |
1 | 1 |
$105,000 |
| Kostopoulos Investment Holdings, LLC |
Level III |
1 | 1 |
$130,000 |
| Lase Innovation, Inc. |
Level I |
1 | 1 |
$90,000 |
| Leica Microsystems Inc. |
Level IV |
1 | 1 |
$175,000 |
| Lonza Biologics Inc. |
Level II |
1 | 1 |
$111,283 |
| Massachusetts Eye and Ear Infirmary |
Level I |
1 | 1 |
$78,900 |
| Massachusetts Eye and Ear Infirmary |
Level II |
1 | 1 |
$70,450 |
| Massachusetts Institute of Technology |
Level II |
1 | 1 |
$75,000 |
| Massachusetts Institute of Technology |
Level III |
1 | 1 |
$93,558 |
| Medtronic, Inc. |
Level III |
1 | 1 |
$119,808 |
| Mevion Medical Systems, Inc. |
Level III |
1 | 1 |
$132,000 |
| Northeastern University |
Level II |
1 | 1 |
$75,000 |
| Northeastern University |
Level III |
1 | 1 |
$86,382 |
| Northeastern University |
Level IV |
1 | 1 |
$102,315 |
| Northstar Group, Inc |
Level I |
1 | 1 |
$86,299 |
| Northstar Group, Inc |
Level II |
1 | 1 |
$103,043 |
| The Ohio State University |
Level III |
1 | 1 |
$86,382 |
| Ovelle Bio Corp. |
Level II |
1 | 1 |
$105,000 |
| pacDNA LLC |
Level III |
1 | 1 |
$125,000 |
| Precision Neuroscience Corporation |
Level IV |
1 | 1 |
$160,000 |
| Qilin Bio Inc. |
Level III |
1 | 1 |
$130,000 |
| Regeneron Pharmaceuticals, Inc. |
Level IV |
1 | 1 |
$154,721 |
| RevBio, Inc. |
Level IV |
1 | 1 |
$136,552 |
| REVVITY HEALTH SCIENCES, INC. |
Level II |
1 | 1 |
$109,814 |
| RoslinCT US Holdings LLC |
Level III |
1 | 1 |
$135,000 |
| Saint-Gobain Ceramics & Plastics, Inc. |
Level III |
1 | 1 |
$119,808 |
| SanaHeal, Inc. |
Level III |
1 | 1 |
$119,808 |
| Sanofi Pasteur Inc. |
Level IV |
1 | 1 |
$136,552 |
| Seedbox Labs, Inc. |
Level IV |
1 | 1 |
$748,800 |
| St. Jude Medical, Cardiology Division, Inc. |
Level II |
1 | 1 |
$110,000 |
| St. Jude Medical, Cardiology Division, Inc. |
Level III |
1 | 1 |
$120,000 |
| Strand Therapeutics Inc. |
Level II |
1 | 1 |
$103,043 |
| SYNMETA LLC |
Level II |
1 | 1 |
$103,043 |
| Takeda Development Center Americas, Inc. |
Level III |
1 | 1 |
$128,544 |
| Takeda Development Center Americas, Inc. |
Level IV |
1 | 1 |
$143,021 |
| TRUSTEES OF BOSTON UNIVERSITY |
Level II |
1 | 1 |
$93,472 |
| TScan Therapeutics, Inc. |
Level II |
1 | 1 |
$103,043 |
| UII America, Inc. |
Level IV |
1 | 1 |
$163,229 |
| VELSSON TECHNOLOGY INC |
Level III |
1 | 1 |
$120,000 |
| Veracyte, Inc. |
Level IV |
1 | 1 |
$143,000 |
| The Veritas Healthcare Solutions LLC |
Level II |
1 | 1 |
$103,043 |
| Versatope Therapeutics, Inc. |
Level I |
1 | 1 |
$86,299 |
| Vertex Pharmaceuticals Incorporated |
Level IV |
1 | 1 |
$184,000 |
| Xellar Inc. |
Level I |
1 | 1 |
$103,000 |
| Xellar Inc. |
Level II |
1 | 1 |
$103,100 |